Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Chicago, IL
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Iowa City, IA
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Ellsworth, ME
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Ellsworth, ME
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Baltimore, MD
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Cambridge, MA
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Waltham, MA
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Waltham, MA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Detroit, MI
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Jackson, MI
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Jackson, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Rochester, MN
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
St. Louis, MO
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Omaha, NE
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Bloomfield, NJ
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Bloomfield, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Palisades Park, NJ
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Teaneck, NJ
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Belmont, NC
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Belmont, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Charlotte, NC
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Fargo, ND
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Beachwood, OH
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Middleburg Heights, OH
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Ashland, OR
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Ashland, OR
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Knoxville, TN
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Memphis, TN
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Austin, TX
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Dallas, TX
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Houston, TX
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Mission, TX
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Mission, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
Clinical Research Facility
mi
from
Norfolk, VA
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated:  7/11/2016
mi
from
Olivos,
Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment
A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment
Status: Enrolling
Updated: 7/11/2016
mi
from
Olivos,
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
McDonald Eye Associates
mi
from
Fayetteville, AR
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
McDonald Eye Associates
mi
from
Fayetteville, AR
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Maloney Vision
mi
from
Los Angeles, CA
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Maloney Vision
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
NVision
mi
from
Newport Beach, CA
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
NVision
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Eye Center NOCO
mi
from
Fort Collins, CO
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Eye Center NOCO
mi
from
Fort Collins, CO
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Kraff Eye Institute
mi
from
Chicago, IL
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Kraff Eye Institute
mi
from
Chicago, IL
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Eye Surgeons of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Durrie Vision
mi
from
Overland Park, KA
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Durrie Vision
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Pepose Vision Institute
mi
from
Chesterfield, MO
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Pepose Vision Institute
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Cornea & Laser Eye Institute
mi
from
Teaneck, NJ
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Cornea & Laser Eye Institute
mi
from
Teaneck, NJ
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
University of Rochester Eye Institute - Strong Vision
mi
from
Rochester, NY
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
University of Rochester Eye Institute - Strong Vision
mi
from
Rochester, NY
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Vance Thompson Vision
mi
from
Sioux Falls, SD
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Vance Thompson Vision
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Hoopes Vision
mi
from
Sandy, UT
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Hoopes Vision
mi
from
Sandy, UT
Click here to add this to my saved trials
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated:  7/11/2016
Davis Duehr Dean
mi
from
Madison, WI
A Continuation Study To Monitor The Long Term Safety Of Patients Completing Protocols ACU-P08-020/020A
A Continuation Study To Monitor The Long Term Safety Of The AcuFocus ™ ACI 7000PDT Patients Completing Protocols ACU-P08-020/020A
Status: Enrolling
Updated: 7/11/2016
Davis Duehr Dean
mi
from
Madison, WI
Click here to add this to my saved trials
Increasing Patching for Amblyopia in Children 3 to < 8 Years Old
Increasing Patching for Amblyopia in Children 3 to < 8 Years Old
Status: Enrolling
Updated:  7/12/2016
Southern California College of Optometry
mi
from
Fullerton, CA
Increasing Patching for Amblyopia in Children 3 to < 8 Years Old
Increasing Patching for Amblyopia in Children 3 to < 8 Years Old
Status: Enrolling
Updated: 7/12/2016
Southern California College of Optometry
mi
from
Fullerton, CA
Click here to add this to my saved trials